ArticleACS applied materials & interfaces2023
Deep Blue and Highly Emissive ZnS-Passivated InP QDs: Facile Synthesis, Characterization, and Deciphering of Their Ultrafast-to-Slow Photodynamics.
Article in ACS applied materials & interfaces, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 21 citations in OpenAlex.
- Indium phosphide quantum dots: advanced synthesis, surface engineering, and biomedical applications in imaging, sensing, and therapy.RSC advances · 2026Review
- Pre-Shell Protection Suppresses Facet-Selective Core Digestion in InP Quantum Dots for High-Yield and Uniform Core/Shell Structures.ACS applied materials & interfaces · 2025Article
- Degradation Mechanisms in Quantum-Dot Light-Emitting Diodes: A Perspective on Nondestructive Analysis.International journal of molecular sciences · 2025Review
- Indirect-to-direct bandgap transition in GaP semiconductors through quantum shell formation on ZnS nanocrystals.Nature communications · 2024Article
- Blue-emitting InP quantum dots participate in an efficient resonance energy transfer process in water.Chemical science · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
InP-based quantum dots (QDs) are an environment-friendly alternative to their heavy metal-ion-based counterparts. Herein we report a simple procedure for synthesizing blue emissive InP QDs using oleic acid and oleylamine as surface ligands, yielding ultrasmall QDs with average sizes of 1.74 and 1.81 nm, respectively. Consecutive thin coating with ZnS increased the size of these QDs to 4.11 and 4.15 nm, respectively, alongside a significant enhancement of their emission intensities centered at ∼410 nm and ∼430 nm, respectively. Pure phase synthesis of these deep-blue emissive QDs is confirmed by powder X-ray diffraction (PXRD), X-ray photoelectron spectroscopy (XPS), and transmission electron microscopy (TEM). Armed with femtosecond to millisecond time-resolved spectroscopic techniques, we decipher the energy pathways, reflecting the effect of successive ZnS passivation on the charge carrier (electrons and holes) dynamics in the deep-blue emissive InP, InP/ZnS, and InP/ZnS/ZnS QDs. Successive coating of the InP QDs increases the intraband relaxation times from 200 to 700 fs and the lifetime of the hot electrons from 2 to 8 ps. The lifetime of the cold holes also increase from 1 to 4 ps, and remarkably, the Auger recombination escalates from 15 to 165 ps. The coating also drastically decreases the quenching by the molecular oxygen of the trapped charge carriers at the surfaces of the QDs. Our results provide clues to push further the emission of InP QDs into more energetically spectral regions and to increase the fluorescence quantum yield, targeting the construction of efficient UV-emissive light-emitting devices (LEDs).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.